Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Koehler

Showing results (21-30 of 126) with videos related to

Pageof 13
Sort By:
Infection|September 20, 2018
'Lost in Nasal Space': Staphylococcus aureus sepsis associated with Nasal Handkerchief PackingPhilipp Koehler, Norma Jung, Matthias Kochanek, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 13, 2023
Which trial do we need? Combination treatment of Pneumocystis jirovecii pneumonia in non-HIV infected patientsPhilipp Koehler, Juergen Prattes, Michaela Simon, et al.
Mycoses|October 28, 2023
Questioning the 14-day dogma in candidemia treatment durationJon Salmanton-García, Ilana Reinhold, Juergen Prattes, et al.
The Journal of Antimicrobial Chemotherapy|January 4, 2021
Validation of the EQUAL Aspergillosis Score by analysing guideline-adherent management of invasive pulmonary aspergillosisSofia Budin, Jon Salmanton-García, Philipp Koehler, et al.
Mycoses|September 6, 2017
Candida-reactive T cells for the diagnosis of invasive Candida infection of the lumbar vertebral spineFelix C Koehler, Oliver A Cornely, Hilmar Wisplinghoff, et al.
Expert Review of Clinical Pharmacology|June 28, 2021
Recent advances and future perspectives in the pharmacological treatment of <i>Candida auris</i> infectionsDaniele R Giacobbe, Laura Magnasco, Chiara Sepulcri, et al.
Medical Mycology|September 8, 2020
Future challenges and chances in the diagnosis and management of invasive mould infections in cancer patientsJörg Janne Vehreschild, Philipp Koehler, Frédéric Lamoth, et al.
Antimicrobial Agents and Chemotherapy|August 29, 2018
Reliable and Easy-To-Use Liquid Chromatography-Tandem Mass Spectrometry Assay for Quantification of Olorofim (F901318), a Novel Antifungal Drug, in Human Plasma and SerumCarsten Müller, Cornelia Fietz, Philipp Koehler, et al.
Emerging Infectious Diseases|December 11, 2025
Bjerkandera spp. Pulmonary Infection in Immunocompromised Hosts, GermanyRosanne Sprute, Danila Seidel, Katrin Mehler, et al.
International Journal of Antimicrobial Agents|August 13, 2018
Rare mould infections caused by Mucorales, Lomentospora prolificans and Fusarium, in San Diego, CA: the role of antifungal combination therapyJeffrey D Jenks, Sharon L Reed, Danila Seidel, et al.
Pageof 13

Showing results (21-30 of 126) with videos related to

Sort By:
Pageof 13
Infection|September 20, 2018
'Lost in Nasal Space': Staphylococcus aureus sepsis associated with Nasal Handkerchief PackingPhilipp Koehler, Norma Jung, Matthias Kochanek, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 13, 2023
Which trial do we need? Combination treatment of Pneumocystis jirovecii pneumonia in non-HIV infected patientsPhilipp Koehler, Juergen Prattes, Michaela Simon, et al.
Mycoses|October 28, 2023
Questioning the 14-day dogma in candidemia treatment durationJon Salmanton-García, Ilana Reinhold, Juergen Prattes, et al.
The Journal of Antimicrobial Chemotherapy|January 4, 2021
Validation of the EQUAL Aspergillosis Score by analysing guideline-adherent management of invasive pulmonary aspergillosisSofia Budin, Jon Salmanton-García, Philipp Koehler, et al.
Mycoses|September 6, 2017
Candida-reactive T cells for the diagnosis of invasive Candida infection of the lumbar vertebral spineFelix C Koehler, Oliver A Cornely, Hilmar Wisplinghoff, et al.
Expert Review of Clinical Pharmacology|June 28, 2021
Recent advances and future perspectives in the pharmacological treatment of <i>Candida auris</i> infectionsDaniele R Giacobbe, Laura Magnasco, Chiara Sepulcri, et al.
Medical Mycology|September 8, 2020
Future challenges and chances in the diagnosis and management of invasive mould infections in cancer patientsJörg Janne Vehreschild, Philipp Koehler, Frédéric Lamoth, et al.
Antimicrobial Agents and Chemotherapy|August 29, 2018
Reliable and Easy-To-Use Liquid Chromatography-Tandem Mass Spectrometry Assay for Quantification of Olorofim (F901318), a Novel Antifungal Drug, in Human Plasma and SerumCarsten Müller, Cornelia Fietz, Philipp Koehler, et al.
Emerging Infectious Diseases|December 11, 2025
Bjerkandera spp. Pulmonary Infection in Immunocompromised Hosts, GermanyRosanne Sprute, Danila Seidel, Katrin Mehler, et al.
International Journal of Antimicrobial Agents|August 13, 2018
Rare mould infections caused by Mucorales, Lomentospora prolificans and Fusarium, in San Diego, CA: the role of antifungal combination therapyJeffrey D Jenks, Sharon L Reed, Danila Seidel, et al.
Pageof 13